Methods and issues associated with the use of quality-adjusted life-years. - Test2 - elhamkhani - TriplyDB

Methods and issues associated with the use of quality-adjusted life-years.

Methods and issues associated with the use of quality-adjusted life-years.

http://www.wikidata.org/entity/Q37978909

about

Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data.The Diagnosis of Urinary Tract Infection in Young Children (DUTY) Study Clinical Rule: Economic Evaluation Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients.Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B.Evaluation of health status in patients with hepatitis c treated with and without interferon.Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.Comparing and transforming PROMIS utility values to the EQ-5D.

P2860

Q26865814-82BFC94A-02BB-4F49-9815-5A7EF0AD6A88 Q31152059-1DD85CC8-9705-412C-9017-ECCC9888544D Q33606555-016AC28B-3661-4077-857D-C969961A0FAD Q38097528-318434C7-2435-4DE4-94F8-8CB8DB7B3A1C Q42224119-9D3007E3-6402-42BF-AB2B-582E3F3BF195 Q47552347-D8A63729-321D-4C22-95CA-DC44F8789CCF Q47947804-5BEF7D82-798D-4FC8-8447-091EAAE32192 Q48372464-A06E29A7-6A49-421A-9B16-3627ABA9531A

P2860

Methods and issues associated with the use of quality-adjusted life-years.

http://www.wikidata.org/entity/Q37978909

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Methods and issues associated with the use of quality-adjusted life-years.

@en

Methods and issues associated with the use of quality-adjusted life-years.

@nl

type

label

Methods and issues associated with the use of quality-adjusted life-years.

@en

Methods and issues associated with the use of quality-adjusted life-years.

@nl

prefLabel

Methods and issues associated with the use of quality-adjusted life-years.

@en

Methods and issues associated with the use of quality-adjusted life-years.

@nl

P1433

Q37978909-73A959F9-C39D-4858-81C8-1775B6541781

P1476

Q37978909-5FD585BB-3E36-433F-BFB8-4C7745D5225E

P2093

Q37978909-32F85D5F-8B8B-4DF1-92E0-F904A556A075

Q37978909-F3736893-86F4-4D3C-B743-4699CBF174B6

P2860

Q37978909-045DA9F6-5779-4135-AB3C-4E23FFB36397

Q37978909-0763C600-FC17-42F7-AF58-1EFB81E2638E

Q37978909-129B74BF-8466-4A4D-AA30-39B72DADEFA4

Q37978909-18323308-251C-4982-97A1-0121C7687E2D

Q37978909-1B9AB3DB-1A42-491D-9A19-48BF2C0566F0

Q37978909-1E576D00-CBD7-4057-A19E-B8A6EC3D90BB

Q37978909-3479ECF6-2DA7-4D3B-AEA0-D746CF25CF77

Q37978909-3D31E77E-946E-4A84-BC63-171398E92B5F

Q37978909-42EEDF50-2C0D-4B09-938F-ABB85B8CD876

Q37978909-5913745A-4055-4CE3-A8AC-597962286F88

P304

Q37978909-EDD5B54C-6317-4268-BBC6-78009CB555C5

P31

Q37978909-A609F106-E32C-452C-A738-59BD1C3E08F7

P356

Q37978909-DD111B58-7CEE-4EBC-B5E9-DC9FDA60CD24

P433

Q37978909-BE611EDC-9937-49F8-B296-F3F2B0145089

P478

Q37978909-4CCBF0DE-3DF1-4B5A-9698-50C84397A9B9

P577

Q37978909-05E7C026-5F6A-435E-90FF-2578E2F70715

P698

Q37978909-B6624413-0C1C-46C3-80F4-5D3A9028585A

P356

P1433

Expert Review of Pharmacoeconomics & Outcomes Research

P1476

Methods and issues associated with the use of quality-adjusted life-years.

@en

P2093

Dennis A Revicki

http://www.w3.org/2001/XMLSchema#string

William R Lenderking

http://www.w3.org/2001/XMLSchema#string

P2860

The MOS 36-ltem Short-Form Health Survey (SF-36)

Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available.

Multi-attribute health status classification systems. Health Utilities Index.

Measurement of health state utilities for economic appraisal.

Valuing health-related quality of life. A review of health state valuation techniques.

EQ-5D: a measure of health status from the EuroQol Group.

The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension.

Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review.

Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function.

US norms for six generic health-related quality-of-life indexes from the National Health Measurement study.

P304

105-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERP.11.100

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22280200

http://www.w3.org/2001/XMLSchema#string